First-in-Human Trials: What Early-Stage Biotech’s Get Wrong About Study Design

Human clinical trials are supposed to answer one simple question: does this treatment work, and is it safe? But the first time a new drug is given to a person, known as a first in human study, is where many biotech programs quietly go wrong. The problem is rarely bad luck. It is usually study […]